Hemogenyx Pharmaceuticals PLC Announces Interim Results for the Period Ended 30 June 2020
LONDON, UK / ACCESSWIRE / September 30, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the Standard Listed biopharmaceutical group developing therapies...
Month: September 2020
TCMD INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Announces the Filing of Investor Class Action Lawsuit against Tactile Systems Technology (TCMD) for Defrauding Investors through Illegal Sales and Marketing Scheme
SAN FRANCISCO--(BUSINESS WIRE)--$TCMD #NASDAQ--Today, leading shareholder rights law firm Hagens Berman filed a securities fraud class action in the U.S....
CureVac: CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate
Study conducted in Peru and Panama Trial involves 690 participants, including older adults Evaluation of safety, reactogenicity and immunogenicity TÜBINGEN,...
DuraSorb® Monofilament Mesh Earns CE Mark Approval
Best-in-class soft tissue support product soon available in Europe for Abdominal Wall, Cosmetic, and Reconstructive Breast Procedures CHICAGO--(BUSINESS WIRE)--Surgical Innovation...
Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples
CHARLOTTESVILLE, VA / ACCESSWIRE / September 29, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...
Perimeter Medical Imaging AI to Present at the Virtual Gravitas Healthcare Investor Day
TORONTO, ON / ACCESSWIRE / September 29, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to...
American Kidney Fund Expands Rare Disease Initiatives with Education and Awareness Campaign About Fabry Disease
Campaign explores Fabry disease as a cause of unexplained chronic kidney disease and empowers people diagnosed with Fabry to educate...
Hepion Pharmaceuticals to Present at H.C. Wainwright’s 4th Annual NASH Virtual Investor Conference
EDISON, NJ / ACCESSWIRE / September 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development...
Limitless Venture Group, Inc. Generates Record Revenues for Fiscal 2020
Recent Acquition Fuels Unprecedented Growth for Holding Company TULSA, OK / ACCESSWIRE / September 29 ,2020 / (OTC PINK:LVGI) Limitless...
Joonghun Pharmaceutical ‘Lorient’ Dermal Filler Receives CE Mark Approval
SEOUL, KOREA / ACCESSWIRE / September 29, 2020 / As of the 26th of August 2020, Joonghun Pharmaceutical's (CEO Sukjoon...
Imagin Medical to Host Kol Webcast Event on October 29, 2020
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / September 29, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or...
Soricimed Continues Critical Research Thanks to Support from the Government of Canada
MONCTON, NB / ACCESSWIRE / September 29, 2020 / Soricimed Biopharma Inc. ("Soricimed" or "the Company"), a clinical-stage company developing...
PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials
HERZLIYA, ISRAEL / ACCESSWIRE / September 29, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical stage specialty...
Compulink Readies EHR Coding Engine to Support E/M 2021 Changes
Company’s EHR will help providers identify best codes to bill for maximum reimbursement NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink Healthcare Solutions, the...
DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic That Predicts COVID-19 Severity Risk
New Data Shows Inflammatix Machine Learning-Based Approach of Reading Immune System is Superior to IL-6 and Other Measures in Predicting...
Michael Porter of Harvard Business School has Joined the Board of Directors of ExThera Medical Corporation
MARTINEZ, Calif.--(BUSINESS WIRE)--Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology...
Neuropore Therapies Licenses Autophagy Modulators to Global Cancer Technology for Treatment of Cancers and Other Life-Threatening Diseases
SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc. announced today that it has licensed two mechanistically distinct classes of potent, selective and brain...
Savonix and Fujitsu Connected Technologies Limited Partner to Introduce Savonix Mobile App on Raku-Raku Smartphone F-42A
Digital Cognitive Testing App Allows Users to Take Charge of Their Brain Health SAN FRANCISCO--(BUSINESS WIRE)--#alzheimers--Savonix, a global leader in...
SphingoTec GmbH: SphingoTec, BHR Pharmaceuticals Ink Agreement for Distribution of SphingoTec’s Acute Care Portfolio in the UK and Ireland
BHR specializes in innovative diagnostic solutions for point of care Collaboration focusses on SphingoTec's proprietary assays for bio-ADM(R), penKid(R) and...
Pharnext to Host Research and Development Day on October 13, 2020
Event to be held virtually as a live webcast PARIS, FRANCE / ACCESSWIRE / September 29, 2020 / Pharnext SA...